Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending August 2011. The report details a specific corporate action regarding the repurchase and cancellation of the company's own ordinary shares, executed under authority granted by shareholders at the Annual General Meeting on May 5, 2011.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on share capital movements.
- Shares Repurchased: 2,300,000 ordinary shares of 25 pence each.
- Repurchase Date: August 19, 2011.
- Price Range: Highest price paid was 1,255.5 pence per share; lowest price paid was 1,213 pence per share.
- Treasury Shares Post-Cancellation: 502,996,816 shares (representing 9.00% of total issued share capital and 9.89% of total voting rights).
- Shares in Issue (Excluding Treasury): 5,088,057,071 shares.
Material Changes
The primary material change reported is the reduction of the company's issued share capital through the cancellation of 2,300,000 repurchased shares. Consequently, the number of shares held in Treasury increased to 502,996,816. The filing does not provide comparative data against prior periods for financial performance.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. It includes a standard disclaimer stating that the announcement does not constitute an offer or solicitation to purchase securities and is made in conformity with the Financial Services Authority's Disclosure and Transparency Rules. No specific risks or contingencies are detailed in this text.
Investor Verification Checklist
- Verify the total number of shares in issue (5,088,057,071) for calculating ownership thresholds under Disclosure and Transparency Rules.
- Confirm the updated Treasury share count (502,996,816) and its impact on voting rights (9.89%).
- Review the Annual General Meeting minutes from May 5, 2011, to understand the full scope of the share buyback authority.
- Note that this filing does not contain quarterly or annual financial results; refer to Form 20-F for comprehensive financial data.